Geistlich Sons
Geistlich is a global leader in regenerative medicine, developing, manufacturing, and distributing advanced medical devices for bone, cartilage, and tissue regeneration. With a history dating back over 170 years, Geistlich is committed to scientific excellence, Swiss quality, and improving patients' quality of life through innovative solutions and research-driven approaches. The company emphasizes scientific research, clinical efficacy, and high-quality standards, with a strong focus on regenerative solutions for dental, orthopedic, and other medical fields. The company also actively engages in social responsibility initiatives, supporting projects worldwide such as coral reef and children's dental projects, and promotes young talent through apprenticeships.
Industries
Nr. of Employees
small (1-50)
Geistlich Sons
Manchester, Manchester, United Kingdom, Europe
Products
Bone substitute materials (bone graft matrix)
Implantable bone substitute matrices derived from natural bone for use in dental and orthopedic bone regeneration procedures.
Resorbable collagen membranes
Resorbable collagen membranes used to support guided tissue and bone regeneration procedures.
Collagen-derived soft-tissue matrices
Matrix products intended to support soft-tissue augmentation and keratinized tissue gain in oral procedures.
Additively manufactured titanium scaffold
Three-dimensional titanium scaffolds produced by additive manufacturing for clinical bone defect reconstruction and guided bone regeneration.
Collagen-based wound-care matrix
Matrix product designed to support advanced wound healing in clinical wound-care applications.
Infection-control medicinal and device products
Products and formulations intended for infection-control use in clinical settings.
Bone substitute materials (bone graft matrix)
Implantable bone substitute matrices derived from natural bone for use in dental and orthopedic bone regeneration procedures.
Resorbable collagen membranes
Resorbable collagen membranes used to support guided tissue and bone regeneration procedures.
Collagen-derived soft-tissue matrices
Matrix products intended to support soft-tissue augmentation and keratinized tissue gain in oral procedures.
Additively manufactured titanium scaffold
Three-dimensional titanium scaffolds produced by additive manufacturing for clinical bone defect reconstruction and guided bone regeneration.
Collagen-based wound-care matrix
Matrix product designed to support advanced wound healing in clinical wound-care applications.
Infection-control medicinal and device products
Products and formulations intended for infection-control use in clinical settings.
Services
Clinical education and training
Courses, congresses, webinars and hands-on workshops (in-person and virtual) for dental and orthopedic professionals; includes distribution of training kits for remote practical training and multilingual congress support.
Research partnerships, foundation grants and consortium coordination
Support and funding of independent research through partnerships and foundations, and coordination of participation in international, grant-funded research consortia to advance regenerative therapies.
Global distribution and sales partnership
Distribution of regenerative medical devices and materials through an international affiliate and distributor network to provide regional market access and logistics support.
Prototype development, material testing and preclinical evaluation
In-house development and iterative testing of prototypes, material formulation, and preclinical evaluation to progress products from concept toward clinical testing and manufacturing readiness.
Clinical education and training
Courses, congresses, webinars and hands-on workshops (in-person and virtual) for dental and orthopedic professionals; includes distribution of training kits for remote practical training and multilingual congress support.
Research partnerships, foundation grants and consortium coordination
Support and funding of independent research through partnerships and foundations, and coordination of participation in international, grant-funded research consortia to advance regenerative therapies.
Global distribution and sales partnership
Distribution of regenerative medical devices and materials through an international affiliate and distributor network to provide regional market access and logistics support.
Prototype development, material testing and preclinical evaluation
In-house development and iterative testing of prototypes, material formulation, and preclinical evaluation to progress products from concept toward clinical testing and manufacturing readiness.
Expertise Areas
- Regenerative biomaterials
- Bone, cartilage and soft-tissue regeneration
- Medical device and implant manufacturing
- 3D bioprinting and biofabrication
Key Technologies
- Deproteinized bone matrix processing
- Collagen membrane fabrication
- Collagen-based soft-tissue matrix design
- 3D bioprinting of collagen scaffolds